Product NDC: | 64764-844 |
Proprietary Name: | edarbi |
Non Proprietary Name: | Azilsartan kamedoxomil |
Active Ingredient(s): | 40 mg/1 & nbsp; Azilsartan kamedoxomil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64764-844 |
Labeler Name: | Takeda Pharmaceuticals America, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA200796 |
Marketing Category: | NDA |
Start Marketing Date: | 20110225 |
Package NDC: | 64764-844-07 |
Package Description: | 5 CARTON in 1 TRAY (64764-844-07) > 1 BLISTER PACK in 1 CARTON > 7 TABLET in 1 BLISTER PACK |
NDC Code | 64764-844-07 |
Proprietary Name | edarbi |
Package Description | 5 CARTON in 1 TRAY (64764-844-07) > 1 BLISTER PACK in 1 CARTON > 7 TABLET in 1 BLISTER PACK |
Product NDC | 64764-844 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Azilsartan kamedoxomil |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110225 |
Marketing Category Name | NDA |
Labeler Name | Takeda Pharmaceuticals America, Inc. |
Substance Name | AZILSARTAN KAMEDOXOMIL |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin 2 Type 1 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Decreased Blood Pressure [PE] |